Tag Archives: pharmaceutical

The Pharmaceutical Industrial Complex: A Deadly Fairy Tale

The country is pacified by a blind belief that the drugs being prescribed to them have been proven safe because our government health agencies have our physical health and well-being in their best intentions. This is a lie, an extraordinarily deadly lie. Iatrogenesis, medically induced injury and death, is the number one cause of death in American medicine annually, since only a small percentage of these deaths are actually reported. Each year more Americans die from preventable deaths due to our medical system than all military causalities in the two world wars combined. This is tantamount to medical genocide. One of the major causes of these deaths is the overmedication of Americans in all ages. The constant need for profits has created an environment that allows the pharmaceutical industrial complex to use their enormous financial and political clout to literally make normal life experiences into new diseases, such as social anxiety disorder, in order to sell its drugs.

How Pharma Can Skew Drug Trial Results: If patients taking a drug die, study may include only those that survived

Drug companies sidestep rules and hide test results, according to researchers in Canada, France and Britain. David Moher of the Ottawa Hospital Research Institute said that there are two ways to let bias creep into a study: 1) decide the study doesn’t show what a drug company wanted to illustrate, and hide the whole thing, or 2) play up the good news in study findings while concealing the bad, known as “outcome reporting bias.”

Pfizer pays $300 million to resolve allegations of off-label marketing of its antipsychotic drug Geodon

“Pfizer targeted pediatrics and adolescents to expand off-label use and maintained on its payroll an army of more than 250 child psychiatrists nationwide. Pfizer regularly paid generous speaking fees to these child psychiatrists to give what were basically promotional lectures about the benefits of Geodon to their peers, who were naturally also child psychiatrists, despite the fact the drug is not FDA-approved or medically indicated to treat children at all.” According to (filing attorney), “the purpose and intent of paying so many child psychiatrists is clear — to gain a foothold within the fastest growing market for antipsychotics — children.”